DUSP6 and ovarian carcinoma: SGK1 and another top upregulated DEG, DUSP1, have both been implicated in chemoresistance and apoptosis inhibition in ovarian cancer (39–41), with our own research showing that a dual inhibitor of DUSP1 and DUSP6 reversed chemoresistance in ovarian cancer cells (42).